UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

Neuropsychopharmacology (New York, N.Y.), 2002-11, Vol.27 (5), p.699-711

2002

Volltextzugriff (PDF)

Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2002-10, Vol.41 (10), p.1205-1215

2002

Volltextzugriff (PDF)

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder

The journal of clinical psychiatry, 2002-12, Vol.63 (12), p.1140-1147

2002

Volltextzugriff (PDF)

Fluoxetine Treatment for Obsessive-Compulsive Disorder in Children and Adolescents: A Placebo-Controlled Clinical Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2001-07, Vol.40 (7), p.773-779

2001

Volltextzugriff (PDF)

Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2002-07, Vol.41 (7), p.776-784

2002

Volltextzugriff (PDF)

Fluoxetine Treatment for Prevention of Relapse of Depression in Children and Adolescents: A Double-Blind, Placebo-Controlled Study

Journal of the American Academy of Child and Adolescent Psychiatry, 2004-11, Vol.43 (11), p.1397-1405

2004

Volltextzugriff (PDF)

Cardiovascular effects of Atomoxetine in children, adolescents, and adults

Drug safety, 2003-01, Vol.26 (10), p.729-740

2003

Volltextzugriff (PDF)

Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder

Pediatrics (Evanston), 2002-12, Vol.110 (6), p.e75-e75

2002

Volltextzugriff (PDF)

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials

Journal of clinical psychopharmacology, 2001-12, Vol.21 (6), p.561-568

2001

Volltextzugriff (PDF)

The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration

Biological Psychiatry, 2004-07, Vol.56 (1), p.3-9

2004

Volltextzugriff (PDF)

Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study

Journal of child and adolescent psychopharmacology, 2006-02, Vol.16 (1-2), p.207

2006

Volltextzugriff (PDF)

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents

Journal of child and adolescent psychopharmacology, 2004-09, Vol.14 (3), p.412-417

2004

Volltextzugriff (PDF)

Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine

The journal of clinical psychiatry, 1998-02, Vol.59 (2), p.49-55

1998

Volltextzugriff (PDF)

Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study

Journal of child and adolescent psychopharmacology, 2006-03, Vol.16 (1-2), p.207-217

2006

Volltextzugriff (PDF)

Recovery from depression, work productivity, and health care costs among primary care patients

General hospital psychiatry, 2000-05, Vol.22 (3), p.153-162

2000

Volltextzugriff (PDF)

Validation of the ADHD Rating Scale as a clirlician administered and scored instrument

Journal of attention disorders, 2001-09, Vol.5 (2), p.107-115

2001

Volltextzugriff (PDF)

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

Journal of child and adolescent psychopharmacology, 2001-09, Vol.11 (3), p.251-265

2001

Volltextzugriff (PDF)

A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer

Psycho-oncology (Chichester, England), 1998-07, Vol.7 (4), p.291-300

1998

Volltextzugriff (PDF)

Is there a relationship between baseline and treatment-associated changes in [3H]-IMI platelet binding and clinical response in major depression?

Neuropsychopharmacology (New York, N.Y.), 1996-01, Vol.14 (1), p.47-53

1996

Volltextzugriff (PDF)

An exploratory factor analysis of the children's depression rating scale-revised

Journal of child and adolescent psychopharmacology, 2006-08, Vol.16 (4), p.482-491

2006

Volltextzugriff (PDF)

FLUOXETINE FOR DEPRESSION RELAPSE PREVENTION

Journal of the American Academy of Child and Adolescent Psychiatry, 2005-10, Vol.44 (10), p.967-968

2005

Volltextzugriff (PDF)

Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment

Journal of clinical psychopharmacology, 2004-02, Vol.24 (1), p.30-35

2004

Volltextzugriff (PDF)

AACAP 2002 Research Forum: Placebo and Alternatives to Placebo in Randomized Controlled Trials in Pediatric Psychopharmacology

Journal of the American Academy of Child and Adolescent Psychiatry, 2004-08, Vol.43 (8), p.1046-1056

2004

Volltextzugriff (PDF)

Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment

The Journal of family practice, 1998-12, Vol.47 (6), p.446-452

1998

Volltextzugriff (PDF)

FLUOXETINE FOR DEPRESSION RELAPSE PREVENTION

Journal of the American Academy of Child and Adolescent Psychiatry, 2005-10, Vol.44 (10), p.966-967

2005

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(44)
magazinearticle
(2)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Humans
(33)
Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Female
(26)
Male
(26)
Medical Sciences
(23)
Biological And Medical Sciences
(22)
Psychiatry
(21)
Adolescent
(19)
Pharmacology. Drug Treatments
(19)
Psychology. Psychoanalysis. Psychiatry
(18)
Psychopharmacology
(18)
Fluoxetine - Therapeutic Use
(17)
Child
(16)
Depressive Disorder - Drug Therapy
(16)
Neuropharmacology
(16)
Adult
(15)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer...,
(15)
Double-Blind Method
(14)
Fluoxetine - Adverse Effects
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder

Fluoxetine Treatment for Obsessive-Compulsive Disorder in Children and Adolescents: A Placebo-Controlled Clinical Trial

Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial

Fluoxetine Treatment for Prevention of Relapse of Depression in Children and Adolescents: A Double-Blind, Placebo-Controlled Study

Cardiovascular effects of Atomoxetine in children, adolescents, and adults

Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials

The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration

Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents

Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine

Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study

Recovery from depression, work productivity, and health care costs among primary care patients

Validation of the ADHD Rating Scale as a clirlician administered and scored instrument

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer

Is there a relationship between baseline and treatment-associated changes in [3H]-IMI platelet binding and clinical response in major depression?

An exploratory factor analysis of the children's depression rating scale-revised

FLUOXETINE FOR DEPRESSION RELAPSE PREVENTION

Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment

AACAP 2002 Research Forum: Placebo and Alternatives to Placebo in Randomized Controlled Trials in Pediatric Psychopharmacology

Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment

FLUOXETINE FOR DEPRESSION RELAPSE PREVENTION

Suchergebnisse filtern